Close Menu

NEW YORK (GenomeWeb) – Danaher today initiated guidance for adjusted diluted EPS for Fiscal Year 2016 in the range of $4.80 to $4.95.

The firm assumed core revenue growth between 2 percent and 3 percent for FY 2016.

The company also reaffirmed adjusted diluted EPS for the fourth quarter of 2015 to be in the range of $1.25 to $1.29. The average Wall Street estimate is for EPS of $1.25 in Q4.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Bloomberg Law writes that the Genetic Information Nondiscrimination Act may work better as a privacy, rather than anti-discrimination, law.

TechCrunch reports that Linda Avey has a new personal genomics startup that's focusing on India.

A new report finds that though the US has increased its activity in science and engineering, its global share of that activity has fallen in some areas, according to Inside Higher Ed.

In Nature this week: genomic analysis of rapeseed, universal target enrichment method for metagenomic sequencing, and more.